Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer.

Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer.

Item
http://www.wikidata.org/entity/Q34811103
Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples.Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.Characterization of Interstrand DNA-DNA Cross-Links Using the α-Hemolysin Protein NanoporeAdjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study.From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs).The development of pyrrolobenzodiazepines as antitumour agents.Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs.Mechanism of cell death resulting from DNA interstrand cross-linking in mammalian cells.A novel assay revealed that ribonucleotide reductase is functionally important for interstrand DNA crosslink repair.Gallium phosphinoarylbisthiolato complexes counteract drug resistance of cancer cells.Insights from HuR biology point to potential improvement for second-line ovarian cancer therapy.
P2860

Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer.

Item
http://www.wikidata.org/entity/Q34811103
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhibition of carboplatin-indu ...... inum-resistant ovarian cancer.
@ast
Inhibition of carboplatin-indu ...... inum-resistant ovarian cancer.
@en
Inhibition of carboplatin-indu ...... inum-resistant ovarian cancer.
@nl
type
label
Inhibition of carboplatin-indu ...... inum-resistant ovarian cancer.
@ast
Inhibition of carboplatin-indu ...... inum-resistant ovarian cancer.
@en
Inhibition of carboplatin-indu ...... inum-resistant ovarian cancer.
@nl
prefLabel
Inhibition of carboplatin-indu ...... inum-resistant ovarian cancer.
@ast
Inhibition of carboplatin-indu ...... inum-resistant ovarian cancer.
@en
Inhibition of carboplatin-indu ...... inum-resistant ovarian cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Inhibition of carboplatin-indu ...... tinum-resistant ovarian cancer
@en
P2093
P2860
P304
P31
P356
10.1158/1078-0432.CCR-10-0832
P407
P433
P478
P50
P577
P698
P921
P932